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Abstract
There has been a growing interest in developing strategies for identifying single-nucleotide
polymorphisms (SNPs) that explain a linkage signal by joint modeling of linkage and association. We
compare several existing methods and propose a new method called the homozygote sharing
transmission-disequilibrium test (HSTDT) to detect linkage and association or to identify SNPs
explaining the linkage signal on chromosome 6 for rheumatoid arthritis using 100 replicates of the
Genetic Analysis Workshop (GAW) 15 simulated affected sib-pair data. Existing methods
considered included the family-based tests of association implemented in FBAT, a transmission-
disequilibrium test, a conditional logistic regression approach, a likelihood-based approach
implemented in LAMP, and the homozygote sharing test (HST). We compared the type I error
rates and power for tests classified into three categories according to their null hypotheses: 1) no
association in the presence of linkage (i.e., a SNP explains none of the linkage evidence), 2) no
linkage adjusting for the association (i.e., a SNP explains all linkage evidence), and 3) no linkage and
no association. For testing association in the presence of linkage, we found similar power among
all tests except for the homozygote sharing test that had lower power. When testing linkage
adjusting for association, similar power was observed between LAMP and HST, but lower power
for the conditional logistic regression method. When testing linkage or association, the conditional
logistic regression method was more powerful than FBAT.
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Background
The availability of high throughput single-nucleotide pol-
ymorphism (SNP) genotyping technologies at more
affordable costs has generated increasing enthusiasm for
genome-wide association study (GWAS) for a wide range
of disorders [1]. How to best analyze dense SNP data is of
great interest to the scientific community. Family-based
association tests model both linkage and association and
thus can better localize the disease locus than linkage
analyses alone and avoid spurious association results due
to population admixture. Recently, there has been a grow-
ing interest in developing methods for identifying SNPs
that account for all the observed linkage evidence [2], a
goal that can be achieved by joint modeling of linkage and
association.
There are three major types of family-based association
tests categorized by their null hypotheses: 1) H0: no asso-
ciation, in the presence of linkage or the tested SNP is in
linkage equilibrium (LE) with all disease loci (denoted
T1); 2) H0: no linkage adjusting for the association, or the
tested SNP is in complete linkage disequilibrium (LD) (r2
= 1) with all disease loci (denoted T2); 3) H0: no linkage
and no association (denoted T3). It is vital to understand
the differences among these hypotheses and the relative
efficiencies of valid tests for each hypothesis. In what fol-
lows, we classify the tests we considered into the three cat-
egories and compare the power and type I error among
them.
Methods
We used all 100 replicates of Genetic Analysis Workshop
15 (GAW15) simulated nuclear families, each containing
both parents and two affected children (Problem 3).
Rheumatoid arthritis is the phenotype in all of our analy-
ses. An initial nonparametric multipoint genome-wide
linkage scan [3] using SNP markers was performed with
Merlin [4]. A linkage peak with mean logarithm of odds
(LOD) score of 79 (from 100 replicates) at about 50 cM
on chromosome 6 was identified. Because this linkage
region is broad, we selected 2102 dense SNPs between 40
and 60 cM under the linkage peak for assessing power of
all methods. In addition, we selected 947 dense SNPs
between 130 and 140 cM on chromosome 6 for evaluat-
ing type I error rates of the null hypothesis T1. Although
the LOD scores range from 3 to 6, these 947 SNPs are far
away from the disease loci (DR, C and D locus) and
should be in LE with the disease loci. For T3, type I error
rates were evaluated using all 16 chromosomes that do
not harbor any disease loci. Available data from controls
were used to determine LD, as measured by r2 between
each of 2102 dense SNPs and the disease loci. For the tri-
allelic DR locus, a generalized R2 was calculated for each
SNP and tested using the LOGISTIC procedure in SAS ver-
sion 8 [5]. For the C and D loci, r2 was estimated using
Haploview [6] and tested using the method proposed by
Sabatti and Risch [7]. For each SNP, the mean r2 from the
100 replicates was used to estimate more accurately LD
with the disease loci. We briefly describe and categorize
each method by its hypotheses. The analyses were per-
formed with knowledge of the "answers".
Family-based association test (FBAT)
Rabinowitz and Laird [8] proposed the family-based asso-
ciation test (FBAT) that is applicable to multiple siblings,
quantitative traits, and incomplete parental genotypes.
FBAT is a valid test of T3. Lake et al. [9] extended FBAT to
a valid test of T1 by incorporating an empirical variance
estimate (FBAT-e).
Conditional logistic regression method
Millstein et al. [10] recently proposed a pseudo-control
approach for joint modeling of linkage and association.
Let g1, g2, gm, gf denote the genotypes at a studied locus for
two affected offspring, mother, and father, respectively.
D1 and D2 are the disease states for the two sibs. Condi-
tional on parental genotypes and their disease states, the
likelihood for the children is
P(g1, g2|gm, gf, D1, D2) = P(g1|gm, gf, D1) × P(g2|g1, gm, gf, D1, 
D2),
which can be modelled as
where g* represents the four possible offspring genotypes;
e12 = E[ibd12|g1, g2, gm, gf], the expected identical-by-
decent (IBD) sharing between g1 and g2 given the observed
marker genotypes and e1* is the expected IBD sharing
between g1 and  . A test of β = 0 is a test of T1 (denoted
Millstein-b), a test of γ = 0 is a test of T2 (denoted Mill-
stein-c), and the two degree of freedom likelihood ratio
test (LRT) of β = 0 and γ = 0 is a test of T3 (denoted Mill-
stein-a).
Likelihood-based approach – LAMP
Li et al. [2] proposed a method to identify SNPs in LD
with the disease locus through estimation of the degree of
LD between the tested SNP and the putative disease locus.
The method is implemented in the software called LAMP.
They use a likelihood function that 1) assumes a single di-
allelic disease locus, 2) assumes no recombination
between the tested SNP and the disease locus, 3) uses dis-
ease-SNP haplotype frequencies and disease penetrances
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as parameters, and 4) can incorporate information from
flanking markers in LE with the tested SNP. Two LRTs are
proposed. The first (denoted as LAMP-LE) assesses
whether the tested SNP is in LE with the disease locus,
while the second (denoted as LAMP-LD) assesses whether
the tested SNP is in complete LD with the disease locus.
Therefore, LAMP-LE is a test of T1 and LAMP-LD is a test of
T2. The statistical significance of these two tests is assessed
empirically by comparing the observed statistic with sim-
ulated null distributions. We exclude flanking short tan-
dem repeat (STR) markers in LD [7] with tested SNPs and
use the remaining STRs in our application of LAMP.
Homozygote Sharing Test (HST)
The HST statistic [11,12] is constructed using a likelihood
function conditional on parental genotypes. It compares
the observed IBD sharing from homozygous and hetero-
zygous parents to determine if a SNP explains partially the
evidence for linkage. HST capitalizes on the fact that par-
ents who are homozygous at all disease loci in a linkage
region should not transmit any alleles preferentially to the
affected siblings, and hence no excess IBD sharing should
be observed from homozygous parents. Additionally, the
IBD sharing from homozygous and heterozygous parents
should be equal for SNPs in LE with all disease loci. For
the intermediate case in which the tested SNP is in partial
LD with disease loci, some increased sharing may be
observed from homozygous parents in a linkage region.
The HST statistic to identify SNPs explaining some of the
linkage evidence is derived from the likelihood ratio of
the following hypotheses H0:1/2 <αhomo = αhet vs. H1: 1/2 ≤
αhomo <αhet, where αhomo and αhet are the probabilities that
an affected sib-pair shares one allele IBD with respect to
homozygous and heterozygous parents, respectively. The
HST is defined as
where   and   denote the number of sib pairs
sharing "j" allele IBD from homozygous and hetero-
zygous parents respectively (j = 0,1). This HST statistic
(denoted HST-LE) is a test of T1. Once subsets of SNPs
explaining some of the linkage evidence have been identi-
fied, one can then test H0: 1/2 = αhomo <αhet vs. H1: 1/2
<αhomo <αhet with the following HST statistic:
Rejection of the null hypothesis indicates that the tested
SNP does not explain fully the linkage evidence. This HST
statistic (denoted HST-LD) is a test of T2. Both HST-LE and
HST-LD are LRTs under independent parental transmis-
sions, equivalent to assuming a multiplicative model of
transmission. Under the null hypothesis of LE between
the tested SNP and disease loci, both HST statistics asymp-
totically follow a chi-square mixture distribution of
, assuming independent parental trans-
missions.
HSTDT – Combination of HST-LE and transmission-
disequilibrium test (TDT)
The original TDT, proposed by Spielman et al. [13], tests
linkage and association between a marker and a disease
locus using ascertained affected individuals and his/her
parental marker information. The TDT can also be used to
test association in a linked region (Spielman and Ewens
[14]) using data that consist of nuclear families with a sin-
gle affected child. The TDT examines the allelic transmis-
sion to the affected child from his/her heterozygous
parents. For families with multiple affected siblings, the
transmissions are correlated among siblings if there is
linkage, and TDT is no longer a valid test of association in
the presence of linkage. To solve this problem, Martin et
al. [15] focused on the set of transmissions from a hetero-
zygous parent shared by all his/her affected children. For
affected sib-pair data and a marker with two alleles M1 and
M2, they showed that for a marker in LE with the disease
loci, the probability that both affected siblings receive M1
(denoted as  ) and the probability that both affected
siblings receive M2 (denoted as  ) from their hetero-
zygous parent are equal. Thus, there should be no over-
transmission of M1 or M2 to affected offspring. In what fol-
lows we use TDT to refer Martin et al.'s strategy, which is
a test of T1 [15]. Note that the TDT does not use informa-
tion from homozygous parents, while HST-LE compares
the observed allele sharing from homozygous and hetero-
zygous parents without considering which allele is over-
transmitted from heterozygous parents. To fully use all
available information to identify whether a SNP explains
some of the linkage evidence, we propose HSTDT, which
combines HST-LE and TDT by decomposing the allele
sharing from heterozygous parents (αhet) into two allele-
specific IBD sharing probabilities (  and  ), to test
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H0:   vs.  H1:
. The HSTDT statistic is
defined as
Similar to HST-LE, HSTDT is a LRT under the assumption
of independent parental transmission. Under the null
hypothesis of LE between the tested SNP and disease loci
(T1), the HSTDT asymptotically follows a chi-square mix-
ture distribution of  , assuming independ-
ent parental transmissions.
The major distinction between homozygote sharing tests
(HST and HSTDT) and other tests of T1 or T2 is that the
former can be used to test if a SNP explains the linkage
peak (by using IBD information at the linkage peak).
When assuming no recombination between the tested
SNP and the presumed disease locus at the linkage peak,
testing association in the presence of linkage is equivalent
to testing whether a SNP partially explains the linkage
peak; while testing no linkage, adjusting for association is
equivalent to testing whether the tested SNP fully explains
the linkage peak. However, when the assumption is vio-
lated, for tests of T1 and T2 other than HST and HSTDT,
one may not be able to claim that the tested SNP explains
the peak linkage evidence but rather that it explains the
linkage evidence at the location of the tested SNP. When
a linkage signal is identified in a linked region, the LOD
score at the linkage peak should be of greatest interest and
is the usual quantity reported. In this report, HST and
HSTDT are applied to identify SNPs explaining the peak
linkage evidence.
Results
SNPs were classified into five groups according to their LD
with the disease loci. In Table 1, the first group (labeled r2
= 0) included 947 dense SNPs between 130 and 140 cM
on chromosome 6 that were used to assess type I error
rates for T1. In Table 2, the first group (labeled r2 = 0, θ =
0.5) included 6597 SNPs from all 16 chromosomes that
did not harbor any disease loci and were used to assess
type I error rates for T3. The remaining SNPs were grouped
by the maximum of the three mean r2 values with the
three disease loci (C, D, and DR). For example, the group
0.1 <r2 <= 0.3 included SNPs with mean r2 between 0.1
and 0.3 with at least one of the disease loci. Power and
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Table 1: Type I error rates and power (in percentage) for testing association in the presence of linkage (T1)
LD group (number of SNPs)
Significance level (%) r2 = 0 
(n = 947)
0 <r2 <= 0.01 
(n = 1751)
0.01 <r2 <= 0.1 
(n = 304)
0.1 <r2 <= 0.3 
(n = 29)
0.3 <r2 <= 0.92 
(n = 18)
FBAT-e 5 4.9 29.1 90.4 100 100
1 1 18.4 85.3 100 100
0.1 0.1 10.4 77.2 99.9 100
Millstein-b 5 4.9 28.6 90.1 100 100
1 1 18 84.9 100 100
0.1 0.1 10.1 76.6 99.9 100
LAMP-LE 5 4.3 22.5 87.8 100 100
1 0.9 14.3 81.8 100 100
0.1 0.1 8.2 73.4 99.8 100
TDT 5 5.1 29.9 90.7 100 100
1 1.1 19.1 85.9 100 100
0.1 0.1 11 78.1 99.9 100
HST-LE 5 5.2 5.9 21.3 49.9 86.9
1 1.1 1.4 10.3 41.8 79.5
0.1 0.1 0.2 4.1 34.1 74.9
HSTDT 5 7.3 29.2 90.2 100 100
1 1.9 18.6 85.3 100 100
0.1 0.3 11 77.9 99.8 100BMC Proceedings 2007, 1(Suppl 1):S38 http://www.biomedcentral.com/1753-6561/1/S1/S38
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type I error rates were assessed at significance levels of 5%,
1%, and 0.1%.
Testing association in the presence of linkage (T1)
Table 1 presents results for tests of T1. All methods have
appropriate type I error rates (r2 = 0), except that HSTDT
has slightly inflated type I error rates. TDT is the most
powerful among these six methods, followed closely by
HSTDT, FBAT-e, Millstein-b and then LAMP-LE. HST-LE
appears to be less powerful.
Testing linkage adjusted for association (T2)
Table 3 presents results for tests of T2. These tests are used
to examine if a SNP explains all the observed linkage evi-
dence. LAMP-LD and HST-LD test whether a SNP is in
complete LD with the disease loci. Equivalently, Millstein-
c tests if there is residual linkage when conditioning on
the genotype covariate of the tested SNP and is essentially
a binary-trait version of the test proposed by Almasy and
Blangero [16]. Because none of the SNPs is in complete
LD with all disease loci, type I error rates cannot be evalu-
ated. HST-LD and LAMP-LD have similar power and are
more powerful than Millstein-c.
Testing linkage or association (T3)
Table 2 presents results for tests of T3. The type I error rates
(r2 = 0, θ = 0.5) of FBAT and Millstein-a are appropriate.
FBAT is less powerful than Millstein-a for SNPs in low LD
with the disease loci. Note that Millstein-a directly uses
IBD between sib pairs in the model, while FBAT uses
allelic transmission from parents to children, possibly
explaining the difference in their ability to pick up the
linkage signal.
Conclusion
With a dense SNP map, it is natural to speculate whether
all disease loci under a linkage peak have been identified
or their contributions to the phenotypic variation are fully
explained by a small subset of SNPs in association with
these disease loci. Recently, there was much interest in
testing whether a SNP can partially or fully account for all
the observed linkage evidence.
We examined several methods for joint linkage and asso-
ciation analysis and identifying SNPs that explain the
linkage evidence. For testing association in the presence of
linkage and for testing linkage or association, all methods
Table 2: Type I error rates and power (in percentage)for testing linkage or association (T3)
LD group (number of SNPs)
Significance level (%) r2 = 0, θ = 0.5 
(n = 6597)
0 <r2 <= 0.01 
(n = 1751)
0.01 <r2 <= 0.1 
(n = 304)
0.1 <r2 <= 0.3 
(n = 29)
0.3 <r2 <= 0.92 
(n = 18)
FBAT 5 5 34.8 92.1 100 100
1 1 23.7 88.4 100 100
0.1 0.1 15 82.6 100 100
Millstein-a 5 5 99.2 100 100 100
1 1 98.2 100 100 100
0.1 0.1 96.3 99.9 100 100
Table 3: Power (in percentage) for testing linkage adjusted for association (T2)
LD group (number of SNPs)
Significance level (%) 0 <r2 <= 0.01 
(n = 1751)
0.01 <r2 <= 0.1 
(n = 304)
0.1 <r2 <= 0.3 
(n = 29)
0.3 <r2 <= 0.92 
(n = 18)
Millstein-c 5 97.3 97.9 97.1 75.6
1 95.4 96.5 93.1 62.7
0.1 93 94.8 85.9 50.8
LAMP-LD 5 100 100 99.9 99.3
1 100 100 99.8 98.8
0.1 100 100 99.8 97.2
HST-LD 5 100 100 100 96.6
1 100 100 100 96.6
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have appropriate type I error rates. For testing association
in the presence of linkage, TDT is most powerful (but only
slightly more powerful than HSTDT, FBAT-e, Millstein-b,
and LAMP). For testing whether a SNP explains all the
linkage evidence, HST and LAMP have similar power and
are more powerful than Millstein-a; the difference in
power may be explained by the difference in type I error,
which we were unable to assess in the GAW15 data set
because there was no single disease locus explaining all of
the linkage evidence. For testing linkage or association, we
found that Millstein-c was more powerful than FBAT.
These conclusions may not extend to study designs other
than nuclear families each with two affected children with
parental genotypes available, a requirement for HST,
HSTDT, and Millstein et al. [10] Furthermore, the exces-
sively high LOD score observed in this study may explain
the slightly inflated type I error rate observed for HSTDT.
In this study, there are three disease loci in the linked
region and they do not contribute equally to the linkage
signal, with the DR locus having a major effect on affec-
tion status. A different scenario may lead to different
results for methods that use linkage peak information to
identify SNPs, explaining the linkage evidence. However,
for a complex disease, there may be multiple disease loci
acting interactively, so methods that do not assume a sin-
gle causal variant would be most helpful in identifying
SNPs associated with disease loci. There is a great need for
developing methods suitable for multiple disease loci.
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